Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PF-431396 |
Trade Name | |
Synonyms | PF431396|PF 431396 |
Drug Descriptions |
PF-431396 is a dual inhibitor of FAK and PTK2B (PYK2), which may result in inhibition of cell growth (PMID: 27793840, PMID: 29303405). |
DrugClasses | FAK inhibitor 15 |
CAS Registry Number | 717906-29-1 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Erlotinib + PF-431396 | Erlotinib PF-431396 | 0 | 0 |
Gefitinib + PF-431396 | Gefitinib PF-431396 | 0 | 0 |
PF-431396 | PF-431396 | 0 | 0 |